Skip to content

Clinical trials

Completed Myeloproliferative Disorders trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Completed Country / region: France Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20053
20071
20081
20101
20111
20133
20145
20153
20172
20181
20197
20204
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
University Hospital, Bordeaux3
AOP Orphan Pharmaceuticals AG2
European Organisation for Research and Treatment of Cancer - EORTC2
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS2
Institut Paoli-Calmettes2
University Hospital, Brest2
Assistance Publique - Hôpitaux de Paris1
Celgene1
Centre Hospitalier Universitaire, Amiens1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders35
Polycythemia Vera12
Primary Myelofibrosis10
Bone Marrow Diseases9
Hematologic Diseases9
Thrombocythemia, Essential9
Leukemia6
Leukemia, Myeloid, Acute5
Leukemia, Myelomonocytic, Chronic5
Myelodysplastic Syndromes5

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.